Insider Trading activities of Dexcom Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $6,467,394.
The total value of stock sales since 2005 is $541,916,017.
The total value of stock option exercises since 2005 is $34,498,305.



Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-07-25 Doubleday Richard (EVP, Chief Commercial Officer) Sale 3,182 87.31 277,820
2016-07-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 10,300 87.33 899,478
2016-07-22 Moy Jeffrey (SVP, Operations) Sale 10,000 88.48 884,800
2016-07-19 Moy Jeffrey (SVP, Operations) Sale 12,843 84.00 1,078,812
2016-07-13 Balo Andrew K (EVP, Clinical and Regulatory) Sale 5,000 80.12 400,600
2016-07-13 Balo Andrew K (EVP, Clinical and Regulatory) Option Ex 5,000 3.19 15,950
2016-07-13 Sayer Kevin R (President & CEO) Sale 7,000 79.92 559,454
2016-07-11 Lister John (General Manager, EMEA) Sale 3,560 79.35 282,493
2016-07-11 Valdes Jorge A (CTO) Sale 32,000 79.36 2,539,552
2016-07-11 Valdes Jorge A (CTO) Option Ex 32,000 7.63 244,160
2016-06-29 Moy Jeffrey (SVP, Operations) Sale 4,557 80.00 364,560
2016-06-29 Balo Andrew K (EVP, Clinical and Regulatory) Sale 5,000 78.10 390,500
2016-06-29 Balo Andrew K (EVP, Clinical and Regulatory) Option Ex 5,000 3.19 15,950
2016-06-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 10,300 77.40 797,189
2016-06-20 Moy Jeffrey (SVP, Operations) Sale 14,418 77.00 1,110,186
2016-06-20 Balo Andrew K (EVP, Clinical, Regulatory) Sale 110,000 75.00 8,250,000
2016-06-20 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 110,000 3.19 350,900
2016-06-20 Sayer Kevin R (President & CEO) Sale 70,000 75.00 5,250,000
2016-06-09 Lister John (General Manager, EMEA) Sale 3,560 73.27 260,855
2016-06-09 Moy Jeffrey (SVP, Operations) Sale 6,910 74.00 511,340
2016-06-09 Valdes Jorge A (CTO) Sale 10,000 73.72 737,150
2016-06-09 Valdes Jorge A (CTO) Option Ex 10,000 7.79 77,900
2016-06-08 Moy Jeffrey (SVP, Operations) Sale 6,866 71.00 487,486
2016-06-08 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 18,239 70.88 1,292,798
2016-06-08 Valdes Jorge A (CTO) Sale 8,038 70.00 562,660
2016-06-07 Roper Jess (SVP, CFO) Sale 3,471 69.00 239,499
2016-05-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,674 63.59 106,446
2016-05-18 Valdes Jorge A (CTO) Sale 20,000 61.75 1,234,940
2016-05-18 Valdes Jorge A (CTO) Option Ex 20,000 9.80 196,000
2016-05-16 Gregg Terrance H (Executive Chairman) Sale 20,000 62.72 1,254,360
2016-05-12 Kahn Barbara (Director) Sale 3,000 60.73 182,175
2016-05-11 Gregg Terrance H (Executive Chairman) Sale 23,600 64.41 1,520,725
2016-05-09 Lister John (General Manager, EMEA) Sale 3,560 62.50 222,500
2016-05-09 Gregg Terrance H (Executive Chairman) Sale 12,168 61.94 753,685
2016-04-27 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 2,361 70.39 166,190
2016-04-27 Valdes Jorge A (CTO) Sale 10,000 70.00 700,000
2016-04-25 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 69.15 115,205
2016-04-25 Roper Jess (SVP, CFO) Sale 3,471 69.00 239,499
2016-04-12 Lister John (General Manager, EMEA) Sale 3,704 65.78 243,649
2016-04-11 Gregg Terrance H (Executive Chairman) Sale 2,169 68.00 147,492
2016-04-04 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 20,600 70.62 1,454,772
2016-04-04 Valdes Jorge A (CTO) Sale 20,000 70.08 1,401,579
2016-04-04 Valdes Jorge A (CTO) Option Ex 20,000 7.79 155,800
2016-03-31 Roper Jess (SVP, CFO) Sale 3,470 69.00 239,430
2016-03-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 61.76 102,893
2016-03-22 Gregg Terrance H (Executive Chairman) Sale 25,000 59.51 1,487,750
2016-03-14 Lister John (General Manager, EMEA) Sale 3,560 63.75 226,964
2016-03-07 Kahn Barbara (Director) Sale 5,000 67.04 335,215
2016-02-18 Lister John (Sr. VP, General Counsel) Sale 3,560 62.50 222,500
2016-01-25 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 73.34 122,182
2016-01-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 10,300 73.24 754,372
2016-01-22 Roper Jess (SVP, CFO) Sale 3,518 72.97 256,701
2016-01-20 Sayer Kevin R (President & CEO) Sale 7,000 75.00 525,000
2016-01-12 Valdes Jorge A (CTO) Sale 5,610 80.17 449,725
2016-01-11 Valdes Jorge A (CTO) Sale 1,641 78.43 128,710
2016-01-08 Lister John (Sr. VP, General Counsel) Sale 3,560 82.57 293,934
2015-12-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 82.22 136,978
2015-12-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 82.26 1,151,598
2015-12-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 10.56 147,910
2015-12-22 Roper Jess (SVP, CFO) Sale 3,417 81.19 277,415
2015-12-17 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 82.52 618,870
2015-12-17 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 3.19 23,925
2015-12-15 Gregg Terrance H (Executive Chairman) Sale 15,000 83.26 1,248,885
2015-12-14 Lister John (Sr. VP, General Counsel) Sale 3,560 82.50 293,682
2015-12-09 Valdes Jorge A (CTO) Sale 10,000 85.58 855,800
2015-12-09 Valdes Jorge A (CTO) Option Ex 10,000 7.52 75,200
2015-12-08 Lister John (Sr. VP, General Counsel) Sale 2,476 87.17 215,820
2015-12-04 Gregg Terrance H (Executive Chairman) Sale 10,000 86.79 867,870
2015-12-04 Gregg Terrance H (Executive Chairman) Option Ex 10,000 6.85 68,500
2015-12-03 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 86.37 647,782
2015-12-03 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 3.19 23,925
2015-12-02 Gregg Terrance H (Executive Chairman) Sale 10,000 87.05 870,530
2015-12-02 Gregg Terrance H (Executive Chairman) Option Ex 10,000 6.85 68,500
2015-11-30 Gregg Terrance H (Executive Chairman) Sale 5,000 86.50 432,500
2015-11-30 Gregg Terrance H (Executive Chairman) Option Ex 5,000 6.85 34,250
2015-11-25 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 87.49 656,190
2015-11-25 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 3.19 23,925
2015-11-25 Gregg Terrance H (Executive Chairman) Sale 15,000 87.53 1,312,905
2015-11-25 Gregg Terrance H (Executive Chairman) Option Ex 15,000 6.85 102,750
2015-11-24 Balo Andrew K (EVP, Clinical, Regulatory) Sale 4,800 86.36 414,532
2015-11-24 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 4,800 3.19 15,312
2015-11-24 Gregg Terrance H (Executive Chairman) Sale 15,497 86.54 1,341,110
2015-11-24 Gregg Terrance H (Executive Chairman) Option Ex 15,497 6.85 106,154
2015-11-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 85.85 143,024
2015-11-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 85.84 1,201,788
2015-11-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 9.80 137,200
2015-11-23 Balo Andrew K (EVP, Clinical, Regulatory) Sale 5,200 86.50 449,800
2015-11-23 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 5,200 3.19 16,588
2015-11-20 Gregg Terrance H (Executive Chairman) Sale 21,903 86.48 1,894,171
2015-11-20 Gregg Terrance H (Executive Chairman) Option Ex 21,903 6.85 150,035
2015-11-19 Gregg Terrance H (Executive Chairman) Sale 100 85.50 8,550
2015-11-19 Gregg Terrance H (Executive Chairman) Option Ex 100 6.85 685
2015-11-18 Roper Jess (SVP, CFO) Sale 7,000 84.36 590,492
2015-11-18 Roper Jess (SVP, CFO) Option Ex 6,000 9.80 58,800
2015-11-16 Gregg Terrance H (Executive Chairman) Sale 15,000 83.48 1,252,275
2015-11-13 Gregg Terrance H (Executive Chairman) Sale 5,000 85.10 425,485
2015-11-13 Gregg Terrance H (Executive Chairman) Option Ex 5,000 6.85 34,250
2015-11-12 Roper Jess (SVP, CFO) Sale 20,000 84.07 1,681,480
2015-11-12 Roper Jess (SVP, CFO) Option Ex 5,500 9.80 53,900
2015-11-11 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 84.50 633,735
2015-11-11 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 3.19 23,925
2015-11-10 Lister John (Sr. VP, General Counsel) Sale 17,500 84.14 1,472,520
2015-11-10 Lister John (Sr. VP, General Counsel) Option Ex 17,500 9.80 171,500
2015-11-10 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 25,000 84.71 2,117,675
2015-11-10 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 25,000 11.84 296,075
2015-11-10 Gregg Terrance H (Executive Chairman) Sale 17,500 85.00 1,487,535
2015-11-10 Gregg Terrance H (Executive Chairman) Option Ex 17,500 6.85 119,875
2015-11-09 Doubleday Richard (EVP, Chief Commercial Officer) Sale 3,000 83.68 251,031
2015-11-09 Doubleday Richard (EVP, Chief Commercial Officer) Option Ex 3,000 8.54 25,628
2015-11-09 Lister John (Sr. VP, General Counsel) Sale 2,475 83.83 207,469
2015-11-09 Valdes Jorge A (CTO) Sale 40,500 83.61 3,386,245
2015-11-09 Valdes Jorge A (CTO) Option Ex 30,000 7.79 233,700
2015-11-09 Gregg Terrance H (Executive Chairman) Sale 5,001 84.69 423,539
2015-11-09 Gregg Terrance H (Executive Chairman) Option Ex 5,001 6.85 34,256
2015-10-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 79.27 132,058
2015-10-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 80.57 1,127,966
2015-10-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 9.80 137,200
2015-10-20 Balo Andrew K (EVP, Clinical, Regulatory) Sale 4,538 81.46 369,670
2015-10-19 Roper Jess (SVP, CFO) Sale 7,000 83.37 583,590
2015-10-19 Roper Jess (SVP, CFO) Option Ex 6,000 9.80 58,800
2015-10-15 Gregg Terrance H (Executive Chairman) Sale 15,000 77.92 1,168,800
2015-10-06 Balo Andrew K (EVP, Clinical, Regulatory) Sale 8,216 82.29 676,086
2015-09-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 4,217 97.00 409,061
2015-09-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 98.08 1,373,148
2015-09-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 9.80 137,200
2015-09-21 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,859 100.72 791,574
2015-09-18 Roper Jess (SVP, CFO) Sale 7,000 101.27 708,904
2015-09-18 Roper Jess (SVP, CFO) Option Ex 6,000 9.80 58,800
2015-09-15 Gregg Terrance H (Executive Chairman) Sale 29,999 96.22 2,886,413
2015-09-15 Gregg Terrance H (Executive Chairman) Option Ex 14,999 6.85 102,743
2015-09-11 Gregg Terrance H (Executive Chairman) Sale 47,500 96.50 4,583,702
2015-09-11 Gregg Terrance H (Executive Chairman) Option Ex 47,500 6.85 325,375
2015-09-10 Gregg Terrance H (Executive Chairman) Sale 52,501 96.92 5,088,501
2015-09-10 Gregg Terrance H (Executive Chairman) Option Ex 52,501 5.02 263,555
2015-09-09 Gregg Terrance H (Executive Chairman) Sale 10,000 91.00 910,000
2015-09-09 Gregg Terrance H (Executive Chairman) Option Ex 10,000 6.85 68,500
2015-09-09 Lord Jonathan T Md (Director) Sale 10,000 90.96 909,599
2015-09-08 Lister John (Sr. VP, General Counsel) Sale 2,642 89.36 236,081
2015-09-08 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 89.53 671,445
2015-09-08 Gregg Terrance H (Executive Chairman) Sale 25,000 90.85 2,271,225
2015-09-08 Gregg Terrance H (Executive Chairman) Option Ex 25,000 6.85 171,250
2015-09-01 Moy Jeffrey (SVP, Operations) Sale 8,881 90.61 804,680
2015-09-01 Valdes Jorge A (CTO) Sale 20,000 91.22 1,824,400
2015-09-01 Valdes Jorge A (CTO) Option Ex 20,000 7.79 155,800
2015-08-28 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 19,854 94.67 1,879,478
2015-08-24 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,666 80.96 134,874
2015-08-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 84.18 1,178,506
2015-08-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 9.80 137,200
2015-08-20 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 92.47 693,502
2015-08-18 Moy Jeffrey (SVP, Operations) Sale 6,029 97.49 587,773

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.